Suppr超能文献

根据(欧盟)第1829/2003号法规对转基因玉米Bt11进行续期授权评估(申请编号:EFSA-GMO-RX-016)。

Assessment of genetically modified maize Bt11 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA-GMO-RX-016).

作者信息

Naegeli Hanspeter, Bresson Jean-Louis, Dalmay Tamas, Dewhurst Ian Crawford, Epstein Michelle M, Firbank Leslie George, Guerche Philippe, Hejatko Jan, Moreno Francisco Javier, Mullins Ewen, Nogué Fabien, Rostoks Nils, Sánchez Serrano Jose Juan, Savoini Giovanni, Veromann Eve, Veronesi Fabio, Álvarez Fernando, Ardizzone Michele, Raffaello Tommaso

出版信息

EFSA J. 2021 Jan 13;19(1):e06347. doi: 10.2903/j.efsa.2021.6347. eCollection 2021 Jan.

Abstract

Following the submission of application EFSA-GMO-RX-016 under Regulation (EC) No 1829/2003 from Syngenta the Panel on Genetically Modified Organisms of the European Food Safety Authority was asked to deliver a scientific risk assessment on the data submitted in the context of the renewal of authorisation application for the insect-resistant and herbicide-tolerant genetically modified maize Bt11, for food and feed uses, excluding cultivation within the European Union. The data received in the context of this renewal application contained post-market environmental monitoring reports, a systematic search and evaluation of literature, updated bioinformatic analyses, and additional documents or studies performed by or on behalf of the applicant. The GMO Panel assessed these data for possible new hazards, modified exposure or new scientific uncertainties identified during the authorisation period and not previously assessed in the context of the original application. Under the assumption that the DNA sequences of the event in maize Bt11 considered for renewal is identical to the sequence of the originally assessed events, the GMO Panel concludes that there is no evidence in renewal application EFSA-GMO-RX-016 for new hazards, modified exposure or scientific uncertainties that would change the conclusions of the original risk assessment on maize Bt11.

摘要

在先正达公司根据(欧盟)第1829/2003号法规提交申请EFSA-GMO-RX-016之后,欧洲食品安全局转基因生物小组被要求就抗虫和耐除草剂转基因玉米Bt11续期授权申请中提交的数据进行科学风险评估,该评估针对食品和饲料用途,不包括在欧盟境内种植。此次续期申请收到的数据包括上市后环境监测报告、文献的系统检索和评估、更新的生物信息学分析,以及由申请人或代表申请人进行的其他文件或研究。转基因生物小组评估了这些数据,以确定在授权期内是否存在新的危害、暴露情况的改变或新的科学不确定性,且这些情况在原始申请中未得到过评估。假设续期所考虑的玉米Bt11事件的DNA序列与最初评估事件的序列相同,转基因生物小组得出结论,续期申请EFSA-GMO-RX-016中没有证据表明存在新的危害、暴露情况的改变或科学不确定性,这些情况会改变对玉米Bt11的原始风险评估结论。

相似文献

本文引用的文献

1
Guidance on allergenicity assessment of genetically modified plants.
EFSA J. 2017 Jun 22;15(6):e04862. doi: 10.2903/j.efsa.2017.4862. eCollection 2017 Jun.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验